BACKGROUND: Dominant mutations in cellular junction proteins are the major cause of arrhythmogenic cardiomyopathy, whereas recessive mutations in those proteins cause cardiocutaneous syndromes such as Naxos and Carvajal syndrome. The Hutterites are distinct genetic isolates who settled in North America in 1874. Descended from <100 founders, they trace their origins to 16th-century Europe. METHODS AND RESULTS: We clinically and genetically evaluated 2 large families of the Alberta Hutterite population with a history of sudden death and found several individuals with severe forms of biventricular cardiomyopathy characterized by mainly left-sided localized aneurysms, regions of wall thinning with segmental akinesis, in addition to typical electric and histological features known for arrhythmogenic right ventricular cardiomyopathy. We identified a homozygous truncation mutation, c.1660C>T (p.Q554X) in desmocollin-2 (DSC2), in affected individuals and determined a carrier frequency of this mutation of 9.4% (1 in 10.6) among 1535 Schmiedeleut Hutterites, suggesting a common founder in that subgroup. Immunohistochemistry of endomyocardial biopsy samples revealed altered expression of the truncated DSC2 protein at the intercalated discs but only minor changes in immunoreactivity of other desmosomal proteins. Recombinant expressed mutant DSC2 protein in cells confirmed a stable, partially processed truncated protein with cytoplasmic and membrane localization. CONCLUSIONS: A homozygous truncation mutation in DSC2 leads to a cardiac-restricted phenotype of an early onset biventricular arrhythmogenic cardiomyopathy. The truncated protein remains partially stable and localized at the intercalated discs. These data suggest that the processed DSC2 protein plays a role in maintaining desmosome integrity and function.
BACKGROUND: Dominant mutations in cellular junction proteins are the major cause of arrhythmogenic cardiomyopathy, whereas recessive mutations in those proteins cause cardiocutaneous syndromes such as Naxos and Carvajal syndrome. The Hutterites are distinct genetic isolates who settled in North America in 1874. Descended from <100 founders, they trace their origins to 16th-century Europe. METHODS AND RESULTS: We clinically and genetically evaluated 2 large families of the Alberta Hutterite population with a history of sudden death and found several individuals with severe forms of biventricular cardiomyopathy characterized by mainly left-sided localized aneurysms, regions of wall thinning with segmental akinesis, in addition to typical electric and histological features known for arrhythmogenic right ventricular cardiomyopathy. We identified a homozygous truncation mutation, c.1660C>T (p.Q554X) in desmocollin-2 (DSC2), in affected individuals and determined a carrier frequency of this mutation of 9.4% (1 in 10.6) among 1535 Schmiedeleut Hutterites, suggesting a common founder in that subgroup. Immunohistochemistry of endomyocardial biopsy samples revealed altered expression of the truncated DSC2 protein at the intercalated discs but only minor changes in immunoreactivity of other desmosomal proteins. Recombinant expressed mutant DSC2 protein in cells confirmed a stable, partially processed truncated protein with cytoplasmic and membrane localization. CONCLUSIONS: A homozygous truncation mutation in DSC2 leads to a cardiac-restricted phenotype of an early onset biventricular arrhythmogenic cardiomyopathy. The truncated protein remains partially stable and localized at the intercalated discs. These data suggest that the processed DSC2 protein plays a role in maintaining desmosome integrity and function.
Entities:
Keywords:
arrhythmogenic right ventricular cardiomyopathy; desmocollin-2; desmosomes; founder population; genetics; homozygous mutation; humans; sudden cardiac death or sudden death
Authors: Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada Journal: Clin Res Cardiol Date: 2014-11-15 Impact factor: 5.460
Authors: Sabine Duchatelet; Lynn M Boyden; Akemi Ishida-Yamamoto; Jing Zhou; Laure Guibbal; Ronghua Hu; Young H Lim; Christine Bole-Feysot; Patrick Nitschké; Fernando Santos-Simarro; Raul de Lucas; Leonard M Milstone; Vanessa Gildenstern; Yolanda R Helfrich; Laura D Attardi; Richard P Lifton; Keith A Choate; Alain Hovnanian Journal: J Invest Dermatol Date: 2018-10-12 Impact factor: 8.551
Authors: Barbara Triggs-Raine; Tamara Dyck; Kym M Boycott; A Micheil Innes; Carole Ober; Jillian S Parboosingh; Alexis Botkin; Cheryl R Greenberg; Elizabeth L Spriggs Journal: Mol Genet Genomic Med Date: 2016-01-19 Impact factor: 2.183
Authors: Philip M Boone; Bo Yuan; Shen Gu; Zhiwei Ma; Tomasz Gambin; Claudia Gonzaga-Jauregui; Mahim Jain; Todd J Murdock; Janson J White; Shalini N Jhangiani; Kimberly Walker; Qiaoyan Wang; Donna M Muzny; Richard A Gibbs; J Fielding Hejtmancik; James R Lupski; Jennifer E Posey; Richard A Lewis Journal: Mol Genet Genomic Med Date: 2015-11-14 Impact factor: 2.183
Authors: Andreas Brodehl; Darrell D Belke; Lauren Garnett; Kristina Martens; Nelly Abdelfatah; Marcela Rodriguez; Catherine Diao; Yong-Xiang Chen; Paul M K Gordon; Anders Nygren; Brenda Gerull Journal: PLoS One Date: 2017-03-24 Impact factor: 3.240
Authors: Andreas Brodehl; Hans Ebbinghaus; Marcus-André Deutsch; Jan Gummert; Anna Gärtner; Sandra Ratnavadivel; Hendrik Milting Journal: Int J Mol Sci Date: 2019-09-06 Impact factor: 5.923
Authors: Jorge A Wong; Henry J Duff; Tiffany Yuen; Louis Kolman; Derek V Exner; Sarah G Weeks; Brenda Gerull Journal: J Am Heart Assoc Date: 2014-12-11 Impact factor: 5.501